share_log

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Benzinga ·  Mar 21 21:05

Gainers

  • Yield10 Bioscience (NASDAQ:YTEN) stock increased by 133.7% to $0.57 during Thursday's pre-market session. The market value of their outstanding shares is at $6.8 million.
  • Immunovant (NASDAQ:IMVT) shares moved upwards by 14.0% to $35.99. The market value of their outstanding shares is at $5.2 billion.
  • argenx (NASDAQ:ARGX) stock moved upwards by 13.24% to $404.22. The market value of their outstanding shares is at $23.9 billion.
  • Virios Therapeutics (NASDAQ:VIRI) shares moved upwards by 11.79% to $0.39. The company's market cap stands at $7.5 million.
  • Aspira Womens Health (NASDAQ:AWH) stock rose 10.79% to $3.85. The company's market cap stands at $39.7 million.
  • CareMax (NASDAQ:CMAX) stock moved upwards by 10.6% to $6.05. The market value of their outstanding shares is at $23.0 million. As per the press release, Q4 earnings came out 3 days ago.

Losers

  • Tourmaline Bio (NASDAQ:TRML) shares decreased by 33.4% to $29.75 during Thursday's pre-market session. The company's market cap stands at $762.9 million. The company's, Q4 earnings came out 2 days ago.
  • Apyx Medical (NASDAQ:APYX) stock fell 16.22% to $1.55. The company's market cap stands at $53.6 million. The company's, Q4 earnings came out today.
  • Immatics (NASDAQ:IMTX) shares declined by 15.49% to $10.18. The market value of their outstanding shares is at $1.0 billion.
  • Biophytis (NASDAQ:BPTS) stock declined by 13.43% to $0.38. The market value of their outstanding shares is at $4.4 million.
  • Exscientia (NASDAQ:EXAI) shares declined by 12.69% to $5.99. The company's market cap stands at $748.3 million. As per the press release, Q4 earnings came out today.
  • Avinger (NASDAQ:AVGR) stock decreased by 12.43% to $2.89. The company's market cap stands at $3.9 million. The company's, Q4 earnings came out yesterday.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment